DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 62 filers reported holding DERMA SCIENCES INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,184,000 | +7.0% | 227,704 | -3.9% | 0.00% | 0.0% |
| Q3 2016 | $1,107,000 | +40.7% | 236,950 | +18.6% | 0.00% | 0.0% |
| Q2 2016 | $787,000 | -25.9% | 199,816 | -41.6% | 0.00% | 0.0% |
| Q1 2016 | $1,062,000 | -5.2% | 342,439 | +39.7% | 0.00% | 0.0% |
| Q4 2015 | $1,120,000 | +125.4% | 245,059 | +132.3% | 0.00% | 0.0% |
| Q3 2015 | $497,000 | -33.4% | 105,480 | +1.2% | 0.00% | 0.0% |
| Q2 2015 | $746,000 | -42.9% | 104,258 | -32.5% | 0.00% | 0.0% |
| Q1 2015 | $1,307,000 | -43.7% | 154,351 | -38.1% | 0.00% | -50.0% |
| Q4 2014 | $2,320,000 | -24.4% | 249,204 | -32.3% | 0.00% | -33.3% |
| Q3 2014 | $3,068,000 | -29.1% | 368,350 | -1.6% | 0.00% | -25.0% |
| Q2 2014 | $4,325,000 | +31.4% | 374,162 | +44.1% | 0.00% | 0.0% |
| Q1 2014 | $3,292,000 | +110.5% | 259,658 | +79.7% | 0.00% | +100.0% |
| Q4 2013 | $1,564,000 | – | 144,519 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 1,994,876 | $24,697,000 | 2.58% |
| Broadfin Capital, LLC | 771,598 | $9,552,000 | 1.70% |
| Raging Capital Management, LLC | 698,401 | $8,646,000 | 1.49% |
| Camber Capital Management LP | 950,000 | $11,761,000 | 1.23% |
| DAFNA Capital Management LLC | 57,009 | $706,000 | 0.77% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 44,027 | $545,000 | 0.67% |
| Baker Brothers Advisors | 2,558,857 | $31,679,000 | 0.45% |
| THB ASSET MANAGEMENT | 430,810 | $5,333,000 | 0.33% |
| EAM Investors, LLC | 100,658 | $1,246,000 | 0.25% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 32,741 | $390,000 | 0.19% |